Alexion Pharmaceuticals (ALXN) 180.08 $ALXN Biogen

New Post Public Reply Private Reply Replies (0) Message Board

Apr 26, 2015 at 2:51 PM

Alexion Pharmaceuticals (ALXN) 180.08 $ALXN

Biogen Earnings Preview: What To Look For
at Investor's Business Daily - Thu Apr 23, 6:45PM CDT
Biogen (BIIB) on Friday morning is expected to report earnings of $3.91 a share, up 58% vs. a year earlier. That would end a three-quarter string of accelerating growth. Sales should show a 25% advance to $2.66 billion, a solid gain but the fourth...
BIIB: 401.71 (-28.57), GILD: 103.69 (-1.52), ALXN: 180.08 (-4.50), ABBV: 66.07 (+1.82), CELG: 118.71 (+2.62)

Alexion Pharmaceuticals (ALXN) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Thu Apr 23, 6:43PM CDT
The following Alexion Pharmaceuticals (ALXN) conference call took place on April 23, 2015, 10:00 AM ET. This is a transcript of that earnings call:
ALXN: 180.08 (-4.50)

Watch for Alexion Pharmaceuticals to Potentially Rebound After Falling 1.92% Yesterday
Comtex SmarTrend(R) - Thu Apr 23, 4:02PM CDT
Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $179.18 to a high of $186.99. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $180.51 on volume of 2.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ALXN: 180.08 (-4.50)

Alexion Pharmaceuticals (ALXN) Stock Fell Today on Missed Earnings, Weak Guidance
at The Street - Thu Apr 23, 3:15PM CDT
Alexion Pharmaceuticals (ALXN) shares dropped after the company reported mixed first quarter financial results and provided weak full year guidance today.
ALXN: 180.08 (-4.50)

Alexion Pharmaceuticals' (ALXN) CEO David Hallal on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Apr 23, 11:56AM CDT

ALXN: 180.08 (-4.50)

AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed
at Investor's Business Daily - Thu Apr 23, 10:46AM CDT
Thursday morning brought a passel of earnings reports from large-cap drugmakers, which the market greeted with a mostly unenthusiastic response. One of the most anticipated reports came from AbbVie (ABBV), which unveiled its first full quarter with...
GILD: 103.69 (-1.52), ALXN: 180.08 (-4.50), ABBV: 66.07 (+1.82), NVS: 104.28 (-1.22)

Alnylam Strengthens Its Clinical Case Once Again
Stephen Simpson, CFA - at Seeking Alpha - Thu Apr 23, 10:27AM CDT

ALNY: 119.01 (+0.29), ISIS: 66.37 (-1.38), PFE: 35.27 (-0.09), ALXN: 180.08 (-4.50)

Alexion Misses Q1 Earnings Estimates, Keeps 2015 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 23, 9:27AM CDT
Alexion Pharmaceuticals first-quarter 2015 earnings (including stock-based compensation expense) of $1.07 per share missed the Zacks Consensus Estimate of $1.18.
BIIB: 401.71 (-28.57), HZNP: 31.75 (+0.97), AVEO: 1.92 (-0.08), ALXN: 180.08 (-4.50)

Alexion Pharmaceuticals (ALXN) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Apr 23, 8:55AM CDT

ALXN: 180.08 (-4.50)

Alexion Pharma revenues up 6%; net income off 43%; guidance maintained
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 8:17AM CDT

ALXN: 180.08 (-4.50)

Alexion (ALXN) Misses on Q1 Earnings, Maintains Outlook - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 23, 6:55AM CDT
Alexion (ALXN) Misses on Q1 Earnings, Maintains Outlook
ALXN: 180.08 (-4.50)

Alexion misses 1Q profit forecasts
Automated Insights - Thu Apr 23, 5:46AM CDT
CHESHIRE, Conn. (AP) _ Alexion Pharmaceuticals Inc. (ALXN) on Thursday reported first-quarter profit of $91.3 million.
ALXN: 180.08 (-4.50)

Alexion Pharmaceuticals misses by $0.05, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 5:32AM CDT

ALXN: 180.08 (-4.50)

Alexion Reports First Quarter 2015 Results
Business Wire - Thu Apr 23, 5:30AM CDT
--- Steady Soliris Growth in PNH and aHUS Worldwide -
ALXN: 180.08 (-4.50)

Forget Google: 5 Top Stocks With Earnings Thursday
at Investor's Business Daily - Wed Apr 22, 6:31PM CDT
Tech titan Google (GOOGL) will make headlines with its quarterly earnings after the close on Thursday. But Google's growth is sluggish and the stock is lackluster. Check out these five stocks with better performance than the search giant, including...
AMZN: 445.10 (+55.11), PCYC: 256.59 (-0.51), MO: 52.07 (-0.28), ALK: 68.30 (+1.96), LUV: 43.49 (+0.23), SBUX: 51.84 (+2.41), GILD: 103.69 (-1.52), ALXN: 180.08 (-4.50), GM: 35.59 (-0.33), GOOGL: 573.66 (+16.20), ABBV: 66.07 (+1.82), PG: 81.00 (+0.05), MSFT: 47.87 (+4.53), DOW: 51.12 (+0.12)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 4:30PM CDT

CAM: 52.81 (+0.03), BBT: 37.78 (-0.08), LAZ: 55.89 (-0.32), JAH: 52.23 (-0.97), ASPS: 23.24 (+0.76), HSY: 94.63 (-0.30), CAB: 54.19 (-3.13), CFX: 48.31 (-0.86), FAF: 37.83 (+0.76), HP: 74.42 (-0.91), KKR: 23.39 (-0.15), AEP: 57.88 (+0.98), DNKN: 54.03 (+2.52), CLFD: 14.25 (+0.04), DAN: 21.81 (+0.01), ABBV: 66.07 (+1.82), CSL: 99.55 (+0.47), CAT: 84.60 (-0.19), BHE: 24.30 (-0.16), AVT: 43.47 (-0.28), IR: 68.63 (-0.43), COR: 50.35 (+0.52), ALK: 68.30 (+1.96), COL: 97.79 (-0.16), BKU: 33.10 (-0.29), BCC: 37.41 (-0.29), MJN: 97.94 (+1.53), IQNT: 19.31 (+0.94), ERIC: 11.41 (-0.17), DGX: 75.81 (+0.60), ALXN: 180.08 (-4.50), DOW: 51.12 (+0.12), DST: 118.00 (+0.99), MDP: 53.90 (-0.78), MMM: 158.99 (-0.67), GRA: 97.07 (+0.11), FCX: 20.82 (+0.75), CLI: 18.68 (-0.03), DHR: 83.30 (-1.39), FNB: 13.12 (-0.07), LUV: 43.49 (+0.23), DPS: 78.86 (-0.09), IVC: 20.68 (+0.14), GMT: 55.80 (+0.15), JNS: 18.51 (unch), DPZ: 113.96 (+4.73), DLX: 67.37 (-0.17), CMS: 35.16 (+0.15), LTM: 71.46 (+0.02), MDSO: 57.59 (+0.05), LLY: 71.58 (-0.82), BMS: 45.56 (+0.84), EQT: 86.59 (-0.95), MHO: 23.59 (+0.38), BTU: 4.49 (-0.01), GPK: 14.74 (+0.01), BAX: 71.14 (-0.37), EQM: 88.01 (+0.87), BEAV: 61.60 (-0.64), GM: 35.59 (-0.33), HUB.B: 109.32 (-1.00), JCI: 52.48 (-0.42)

Alexion reports tomorrow
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 11:18AM CDT

ALXN: 180.08 (-4.50)

Will Alexion's (ALXN) Soliris Drive Q1 Earnings Beat? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 4:10PM CDT
Alexion Pharmaceuticals, Inc. is scheduled to report first-quarter 2015 earnings results on Apr 23 before the opening bell.
BIIB: 401.71 (-28.57), IMGN: 9.96 (-0.29), ALXN: 180.08 (-4.50), ABBV: 66.07 (+1.82)

Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019 with Alexion Pharmaceuticals, Amgen, Celgene, F. Hoffmann- La Roche, GlaxoSmithKline & Incyte Dominating
PR Newswire Europe - Mon Apr 20, 10:13AM CDT
DUBLIN, Apr. 20, 2015 /PRNewswire/ --Research and Markets
ALXN: 180.08 (-4.50), AMGN: 167.91 (-1.26), CELGZ: 2.76 (-0.12)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson Controls FY26 Results Highlight Growth Momentum

Unpacking Johnson Controls' Fiscal 2026 Performance You know, it's not often that a company hits a home run with back-to-back quarters, but Johnson Controls (NYSE:JCI) seems to be swinging for the fences as they wrap up fiscal 2026. What we've got here is a robust set of financial results, showcasing not just growth but momentum that's got investors humming. We're talking...

EZRA Loop Fuses Human Insight and AI for Managers

Hybrid Coaching: The Future is Here If someone told me five years ago that human coaches and AI would team up to churn out better business leaders, I'd have a laugh. But here we are with EZRA Loop, an inventive mix of flesh-and-blood wisdom and algorithmic precision hitting the streets. This might seem like the latest buzzword pie in the sky to some, but there's a real...

IBM Targets AI Agent Security with New Releases

The AI Agent Surge: A Governance Challenge Platforms are hungry for AI agents, but enterprises are drowning in a sea of responsibilities. They bring in these digital workers, pumping them up like competitors puffing their chests. But there's a hitch: you can’t let these agents run wild in sensitive systems, or it’ll be chaos—like letting a bull loose in a china...

Ensign Group Faces Securities Fraud Lawsuit Amid Scandal

Ensign's Legal Storm: Investors on Edge Man, you can't ignore the weighty allegations pounding on Ensign Group's door right now. The skilled nursing giant, under the ticker NASDAQ:ENSG, is feeling the heat from a securities class action filed against them, and my gut tells me this isn't going to blow over quietly. This case sure looks like a financial tempest that could...

SoftwareOne Secures Leadership in Gartner Report Again

A Glance at SoftwareOne's Unyielding Dominance Call it a streak, call it consistency—either way, SoftwareOne's nailed it yet again, bagging the Leader spot in Gartner's Magic Quadrant for SAM Managed Services for the seventh straight year. Yep, seven years running. This ain't just a piece of paper to hang on the office wall. It's a testament to their grit in helping...

Midland, Michigan Tops 2027 Retirement Destinations

Down-to-Earth Findings for Retirees in 2027 Look, when we're talking about settling down after years of the daily grind, it's crystal clear what folks really care about: not blowing through their savings in a heartbeat. No wonder Midland, Michigan, nailed the No. 1 spot yet again in U.S. News & World Report's 2027 Best Places to Retire. And this ain't just a fluke; they...

Co-Diagnostics Nearing India TB Test Launch By 2026

Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...

Perpetua Wins $40M U.S. Army Deal: Eyes Tungsten Boost

Perpetua's Strategic Move in Mineral Exploration Forget the sleazy diner talk for a sec. We're diving into a strategic American push to revive homegrown tungsten supply. Perpetua Resources is dancing a new jig with a solid $40 million award from the U.S. Army, assisting in this military-driven goal through the Defense Ordnance Technology Consortium. Talk about a smart...

Pizza & Hope: Little Caesars Serves WV Communities

Rolling Out Dough and Kindness in West Virginia In a world that's more uncertain than a penny stock, here comes a story that'll warm even the coldest heart: Little Caesars is sending their Love Kitchen into West Virginia, aiming to serve piping hot pizza to about 8,000 folks in need. Fueled by the efforts of local franchisee Vicki Dunn-Marshall and her team, they're...

China Leads Electrification; US Faces Stagnation Risk

China Races Ahead in Electrification If you ever doubted China's resolve to lead the green charge, the latest Electrification Competitiveness Index should make you think again. They're pacing ahead, while the rest of the world seems content with playing catch-up. Created by the savvy folks over at We Mean Business Coalition with RMI's backing, this index sizes up the...